Fact CheckerSign in

NCT05534360Not yet recruiting

Tenecteplase Treatment in Ischemic Stroke Registry

Source: ClinicalTrials.gov · Last updated 9 Sept 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The Tenecteplase Treatment in Acute Ischemic Stroke (TETRIS) Registry is multicenter ambispective observational study of patients with acute ischemic stroke who received intravenous thrombolysis with Tenecteplase

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
6 Sept 2022
Start date
Sept 2022
Primary completion date
Mar 2028
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
Stroke
NCT number
NCT05534360

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From Sept 2022 to the primary completion date, Mar 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Venous ischemic stroke

Other

  • Contra-indication to intravenous thrombolysis
  • Intravenous thrombolysis with alteplase

Who the study is looking for

  • Age 18 and older
  • Confirmed acute arterial ischemic stroke on brain imaging (CT or MRI) within 270 minutes of symptoms onset or with perfusion CT or MRI criteria for an extended treatment window or wake-up strokes.
  • Intravenous thrombolysis with tenecteplase

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Service des Urgences Cérébro-Vasculaires, Hôpitaux Universitaires Pitié-Salpêtrière et Saint-Antoine
Coordinator of this site? Confirm its status
ParisFranceUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.